Northern Trust
CDIO icon

Northern Trust’s Cardio Diagnostics CDIO Stock Holding History

Northern Trust’s Portfolio CDIO Stock Details CDIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-1,621
Closed -$16K – 4419
2025
Q1 		$16K Hold
1,621
– – ﹤0.01% 4360
2024
Q4 		$44.6K Hold
1,621
– – ﹤0.01% 4274
2024
Q3 		$10.8K Hold
1,621
– – ﹤0.01% 4375
2024
Q2 		$26.7K Buy
1,621
+744
+85% +$17.5K ﹤0.01% 4301
2024
Q1 		$37.3K Sell
877
-660
-43% -$37.6K ﹤0.01% 4266
2023
Q4 		$115K Buy
+1,537
New +$53.2K ﹤0.01% 4080

Other funds holding CDIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Northern Trust's CDIO Position: Q2 2025 in Review

Northern Trust sold out of Cardio Diagnostics (CDIO) in Q2 2025, closing a stake of 1,621 shares — an estimated $16K sold.

Northern Trust first reported a position in CDIO in Q4 2023 and held it in 6 quarters. The position peaked at $115K in Q4 2023. 16 funds tracked by Wall St. Rank hold CDIO as of Q2 2025.

  • Northern Trust reported no remaining Cardio Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Northern Trust sold 1,621 Cardio Diagnostics shares in Q2 2025, an estimated $16K.
  • Northern Trust first reported a position in Cardio Diagnostics in Q4 2023 and held it in 6 quarters.
  • Northern Trust's Cardio Diagnostics position peaked at $115K in Q4 2023.
  • 16 funds tracked by Wall St. Rank held Cardio Diagnostics as of Q2 2025.

Based on Northern Trust's 13F filing for Q2 2025, filed 13 Aug 2025.